These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32165608)

  • 1. Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina Pectoris.
    Long M; Li L
    Med Sci Monit; 2020 Mar; 26():e920721. PubMed ID: 32165608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Uric Acid and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Unstable Angina Pectoris.
    Wei H; Liu Y; Wen H
    Am J Med Sci; 2020 Jul; 360(1):64-71. PubMed ID: 32423749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal Pro-B-Type Natriuretic Peptide Levels Inversely Correlated With Heart Rate Variability in Patients With Unstable Angina Pectoris.
    Dufang M; Yongcheng W; Ping J; Yonghui Y; Xiao L
    Int Heart J; 2016 May; 57(3):292-8. PubMed ID: 27170473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes.
    Hong SN; Yoon NS; Ahn Y; Lim SY; Kim YS; Yun KH; Kang DK; Lee SH; Lee YS; Kim KH; Son IS; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Circ J; 2005 Dec; 69(12):1472-6. PubMed ID: 16308494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
    Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
    Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure mortality according to acute variations in N-terminal pro B-type natriuretic peptide and cystatin C levels.
    Carrasco-Sánchez FJ; Pérez-Calvo JI; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio I; Barón-Franco B; Aguayo-Canela M; Pujol-De la llave E
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):115-21. PubMed ID: 24522084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of serum N-terminal pro-brain natriuretic peptide levels for prognosis of patients in intensive care unit].
    Liu J; Zhang X; Liu Y; Wang B; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):489-92. PubMed ID: 25027427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of cystatin-C to evaluate the prognosis of acute heart failure: A comparative study.
    Kim TH; Kim H; Kim IC
    Acute Card Care; 2015 Dec; 17(4):72-76. PubMed ID: 27494366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
    Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Cystatin C and Cardiac Function and Long-Term Prognosis in Patients with Chronic Heart Failure.
    Wu X; Xu G; Zhang S
    Med Sci Monit; 2020 Feb; 26():e919422. PubMed ID: 32062670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cystatin C and heart failure with preserved ejection fraction in elderly Chinese patients.
    Xu CC; Fu GX; Liu QQ; Zhong Y
    Z Gerontol Geriatr; 2018 Jan; 51(1):92-97. PubMed ID: 27206415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later.
    Kuh D; Cooper R; Sattar N; Welsh P; Hardy R; Ben-Shlomo Y
    Circulation; 2019 Apr; 139(17):1988-1999. PubMed ID: 30667283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes.
    Weber M; Kleine C; Keil E; Rau M; Berkowitsch A; Elsaesser A; Mitrovic V; Hamm C
    Clin Res Cardiol; 2006 May; 95(5):270-80. PubMed ID: 16598393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function.
    Wei G; Ningfu W; Xianhua Y; Liang Z; Jianmin Y; Guoxin T; Peng X
    J Interv Cardiol; 2012 Apr; 25(2):126-31. PubMed ID: 22150844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.